Utah 2025 Regular Session

Utah House Bill HB0146

Introduced
1/21/25  
Refer
1/22/25  
Report Pass
1/24/25  
Engrossed
1/31/25  
Refer
2/4/25  
Report Pass
2/10/25  
Enrolled
3/6/25  

Caption

Mammography Amendments

Impact

The most significant alteration stemming from this bill is the removal of the notification requirement under Section 26B-2-605. This repeal means that certified mammogram facilities will no longer be under the legal obligation to inform women about cancer screening results in a specified manner, allowing for more flexibility in patient communication. The intent behind this move appears to be aimed at reducing regulatory burdens on healthcare providers, particularly mammography facilities, promoting their operational efficiency.

Summary

House Bill 0146, known as the Mammography Amendments, seeks to modify existing regulations regarding cancer screening notifications from the Department of Health and Human Services in Utah. The bill primarily repeals the women's cancer screening notification requirement previously mandated by state law. This change is predicted to impact the way mammography facilities communicate with patients about their screenings and subsequent clinical follow-ups.

Sentiment

The sentiment surrounding HB 0146 reflects a mix of optimism and concern. Proponents of the bill may argue that removing mandatory notification can streamline processes and potentially reduce confusion over communications from medical facilities. However, the sentiment among critics raises alarms about the potential repercussions of less consistent communication to patients, which could delay crucial information about their health status.

Contention

Notable points of contention regarding this legislation might revolve around the implications of diminished patient notification standards. Opponents could argue this repeal jeopardizes critical patient care protocols, risking that women may not receive timely or adequate information regarding their mammogram results. This debate highlights fundamental concerns relating to medical compliance, patient rights, and the balance between regulatory oversight and healthcare provider autonomy.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.